Delivery Order SPE2DE24DA010-SPE2D626F27PU
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on January 20, 2026, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, is scheduled for completion by January 23, 2026, and will be performed at Abbott's location in Santa Clara, California. This award represents a task order issued under the Defense Logistics Agency's...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $28,350 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price contract with economic price adjustment is scheduled for completion by January 20, 2026, and will be performed in Santa Clara, California. The delivery order carries no set-aside designation and was awarded through full and open competition, reflecting Abbott's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $17,803.40 on January 9, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment authority is scheduled for ultimate completion by January 14, 2026, and will be performed in Santa Clara, California. The award was made through full and open competition with no set-aside designation, reflecting Abbott's competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $5,695.00 on January 26, 2026, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price contract with economic price adjustment will be performed in Santa Clara, California, with an ultimate completion date of January 29, 2026. The award was made through full and open competition with no set-aside designation, reflecting Abbott's established competitive positioning as a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $28,350 from the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 20, 2026. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries no set-aside designation, reflecting full and open competition. Performance will take place in Santa Clara, California, where Abbott maintains...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award (Contract No. 4570109351) valued at $6,874.00 from the Defense Logistics Agency's Medical Supply Chain on November 25, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and is scheduled for ultimate completion by December 1, 2025. The award carries no set-aside designation and represents a discrete delivery order issued under Abbott's established...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F27PUDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $8,483.00 delivery order (Contract No. 4570636548) by the Defense Logistics Agency's Medical Supply Chain on January 26, 2026. This fixed-price contract with economic price adjustment pricing carries a completion date of January 30, 2026 and will be performed in Santa Clara, California. The award utilizes full and open competition with no set-aside designation, reflecting Abbott's established competitive positioning as a cardiovascular medical device supplier to federal healthcare systems. This delivery order represents a modest task order under Abbott's broader federal contracting portfolio, which includes a substantial $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive cardiovascular procedural packages. Abbott Vascular has established itself as a critical supplier of advanced cardiovascular technologies to the Department of Defense and Defense Health Agency, providing specialized implantable devices including stents, pacemakers, heart valves, left ventricular assist devices, and transcatheter valve repair systems. The short performance window and ceiling value indicate this is likely a discrete procurement of cardiovascular medical devices or accessories to support military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 1/25/26 |